641. Structured Benefit–risk assessment: a review of key publications and initiatives on frameworks and methodologies. (15th May 2015) Authors: Mt‐Isa, Shahrul; Ouwens, Mario; Robert, Veronique; Gebel, Martin; Schacht, Alexander; Hirsch, Ian Other Names: Kieser Meinhard guestEditor. Journal: Pharmaceutical statistics Issue: Volume 15:Number 4(2016) Page Start: 324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
642. Study design aspects and inter‐subject variability in longitudinal clinical phase II dose‐finding trials. (8th January 2019) Authors: Kennes, Lieven Nils; Volkers, Gisela; Kralidis, Georg Journal: Pharmaceutical statistics Issue: Volume 18:Number 2(2019) Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
643. Study‐design in pandemics: From surveillance and performance‐evaluation to licensing and pharmacovigilance. (12th July 2022) Authors: Bird, Sheila M. Other Names: Senn Stephen guestEditor.; Smith Mike K. guestEditor. Journal: Pharmaceutical statistics Issue: Volume 21:Number 4(2022) Page Start: 764 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
644. Subgroup analyses in cost‐effectiveness analyses to support health technology assessments. (15th June 2014) Authors: Fletcher, Christine; Chuang‐Stein, Christy; Paget, Marie‐Ange; Reid, Carol; Hawkins, Neil Journal: Pharmaceutical statistics Issue: Volume 13:Number 4(2014:Jul./Aug.) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
645. Subgroup analysis and interpretation for phase 3 confirmatory trials: White paper of the EFSPI/PSI working group on subgroup analysis. (27th December 2018) Authors: Dane, Aaron; Spencer, Amy; Rosenkranz, Gerd; Lipkovich, Ilya; Parke, Tom Journal: Pharmaceutical statistics Issue: Volume 18:Number 2(2019) Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
646. Subgroup‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination. (15th August 2018) Authors: Chapple, Andrew G.; Thall, Peter F. Journal: Pharmaceutical statistics Issue: Volume 17:Number 6(2018) Page Start: 734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
647. Subject‐level matching for imbalance in cluster randomized trials with a small number of clusters. (25th June 2013) Authors: Leon, Andrew C.; Demirtas, Hakan; Li, Chunshan; Hedeker, Donald Journal: Pharmaceutical statistics Issue: Volume 12:Number 5(2013:Sep./Oct.) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
648. Survival trial design and monitoring using historical controls. (15th June 2016) Authors: Wu, Jianrong; Xiong, Xiaoping Journal: Pharmaceutical statistics Issue: Volume 15:Number 5(2016) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
649. Synergy evaluation of non‐normalizable dose–response data: Generalization of combination index for the linear effect of drugs. (25th March 2021) Authors: Novotný, Branislav; Nagy, Milan; Kurin, Elena Journal: Pharmaceutical statistics Issue: Volume 20:Number 6(2021) Page Start: 982 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
650. Teaching examples for the design of experiments: geographical sensitivity and the self‐fulfilling prophecy. (12th November 2015) Authors: Lendrem, Dennis W.; Lendrem, B. Clare; Rowland‐Jones, Ruth; D'Agostino, Fabio; Linsley, Matt; Owen, Martin R.; Isaacs, John D. Journal: Pharmaceutical statistics Issue: Volume 15:Number 1(2016) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗